Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beam Therapeutics Inc.

https://beamtx.com

Latest From Beam Therapeutics Inc.

Deal Watch: How Did J.P. Morgan Deal-Making Compare To Prior Years?

Licensing deals and partnerships carried the day during another hectic J.P. Morgan Healthcare Conference. Pfizer racked up its third deal of the week in a cancer collaboration with Dren Bio.

Deal Watch Business Strategies

Intellia To Take On Pfizer Blockbuster With Gene-Editing Therapy

After achieving a landmark in gene-editing with NTLA-2001, Intellia moves to expand its reach into a larger market.

Companies Clinical Trials

Deals Or No Deals, J.P. Morgan Sets The Tone For 2022

No big buyouts were revealed during the annual J.P. Morgan Healthcare Conference for a third year in a row. Big pharma firms are in acquisition mode, but execs stress desire for easy integrations and scientific alliances. 

Deals M & A

Beam Anticipates Pfizer Deal Will Lead To Additional Partnerships

The $300m upfront payment should provide considerable runway for the base-editing company, which also plans multiple IND filings and enrolling the first patient in its sickle cell study this year.

Business Strategies Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Guide Therapeutics, Inc.
UsernamePublicRestriction

Register